title: Chronic nitric oxide blockade modulates renal Na-K-2Cl cotransporters.
abstract: OBJECTIVE
  The Na-K-2Cl cotransporter (NKCC2 isoform) of the thick ascending limb of Henle's loop (TAL) plays an important role in renal sodium handling, and the vascular isoform (NKCC1) participates in the response to vasoconstrictors. Both isoforms appear to be regulated by nitric oxide. This study aimed to analyze the effect of chronic nitric oxide deficiency on tubular and vascular Na-K-2Cl cotransporters in kidney and their potential role in the development of N-nitro-L-arginine-methyl ester (L-NAME) hypertension.
  
  
  METHODS
  Wistar rats were given L-NAME (vehicle, 10, 35 and 80 mg/100 ml drinking water) for 4 weeks. Blood pressure was measured by the tail-cuff method. NKCC2 activity was estimated as the bumetanide-sensitive Rb influx in fresh isolated TAL tubules. NKCC1-contractile function was estimated as the bumetanide-sensitive vasocontractile response to phenylephrine in isolated perfused kidneys. Acute effects of L-NAME and endothelium removal were also evaluated. NKCC2 and NKCC1 protein expression were assessed by western blot analysis.
  
  
  RESULTS
  Chronic L-NAME administration increased, in a dose-dependent manner, both blood pressure and NKCC2 activity, and these changes significantly correlated (r2 = 0.89, P < 0.01). NKCC1-contractile activity decreased with the highest dose of L-NAME (80 mg/100 ml drinking water group) but it was not affected by acute nitric oxide blockade or endothelium removal. This 80 mg group showed increased NKCC2 expression in the renal medulla and decreased NKCC1 expression in aorta.
  
  
  CONCLUSIONS
  Chronic nitric oxide deficiency stimulates tubular Na-K-2Cl cotransporter, suggesting that NKCC2 hyperactivity contributes to the inability to excrete sodium, and hence to the development of L-NAME hypertension. In contrast, L-NAME hypertension develops independently of vascular NKCC1-contractile activity.
authors.affiliation: Area de Fisiología, Universidad de Jaén, Spain.
authors.forename: Rosemary
authors.initials: R
authors.lastname: Wangensteen
authors.forename: Isabel
authors.initials: I
authors.lastname: Rodríguez-Gomez
authors.forename: Juan Manuel
authors.initials: JM
authors.lastname: Moreno
authors.forename: Félix
authors.initials: F
authors.lastname: Vargas
authors.forename: Miriam
authors.initials: M
authors.lastname: Alvarez-Guerra
mesh_terms: D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D009569:Nitric Oxide / Q000037:antagonists & inhibitors* / Q000172:deficiency; D051381:Rats; D017208:Rats, Wistar; D028021:Sodium-Potassium-Chloride Symporters / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D028021:Sodium-Potassium-Chloride Symporters; D009569:Nitric Oxide; D019331:NG-Nitroarginine Methyl Ester